Some studies highlight metabolic distinctions, with LSCs in the CD34+CD38− fraction usually exhibiting lower aldehyde dehydrogenase (ALDH) activity than residual normal HSCs in AML bone marrows (Schuurhuis et al., 2013). The gene discussed is CD34; the disease is acute myeloid leukemia.